Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/cns.12542 http://scihub22266oqcxt.onion/10.1111/cns.12542 C5071655!5071655!27297686     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       CNS+Neurosci+Ther 2016 ; 22 (7): 568-76 Nephropedia Template TP {{tp|p=27297686|t=2016. Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment |pdf=|usr=}}{{27297686}} gab.com Text Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment JO: CNS Neurosci Ther http://www.kidney.de/pget.php?&tw=1&pmid=27297686 #FOAvip Aims: Patients with Fabry disease (FD) characteristically develop peripheral neuropathy at an early age, with pain being a crucial symptom of underlying pathology. However, the diagnosis of pain is challenging due to the heterogeneous and nonspecific symptoms. Practical guidance on the diagnosis and management of pain in FD is needed. Methods: In 2014, experts met to discuss recent advances on this topic and update clinical guidance. Results: Emerging disease?specific tools, including FabryScan, Fabry?specific Pediatric Health and Pain Questionnaire, and Würzburg Fabry Pain Questionnaire, and more general tools like the Total Symptom Score can aid diagnosis, characterization, and monitoring of pain in patients with FD. These tools can be complemented by more objective and quantifiable sensory testing. In male and female patients of any age, pain related to FD can be an early indication to start disease?specific enzyme replacement therapy before potentially irreversible organ damage to the kidneys, heart, or brain occurs. Conclusion: To improve treatment outcomes, pain should be diagnosed early in unrecognized or newly identified FD patients. Treatment should include: (a) enzyme replacement therapy controlling the progression of underlying pathology; (b) adjunctive, symptomatic pain management with analgesics for chronic neuropathic and acute nociceptive, and inflammatory or mixed pain; and (c) lifestyle modifications. Twit Text FOAVip Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment ????CNS Neurosci Ther http://www.kidney.de/pget.php?&tw=1&pmid=27297686 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27297686 #FOAvip English Wikipedia <ref>{{Cite pmid|27297686}}</ref> Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment #MMPMID27297686 Politei JM; Bouhassira D; Germain DP; Goizet C; Guerrero?Sola A; Hilz MJ; Hutton EJ; Karaa A; Liguori R; Üçeyler N; Zeltzer LK; Burlina A CNS Neurosci Ther 2016[Jul]; 22 (7): 568-76 PMID27297686show ga Aims: Patients with Fabry disease (FD) characteristically develop peripheral neuropathy at an early age, with pain being a crucial symptom of underlying pathology. However, the diagnosis of pain is challenging due to the heterogeneous and nonspecific symptoms. Practical guidance on the diagnosis and management of pain in FD is needed. Methods: In 2014, experts met to discuss recent advances on this topic and update clinical guidance. Results: Emerging disease?specific tools, including FabryScan, Fabry?specific Pediatric Health and Pain Questionnaire, and Würzburg Fabry Pain Questionnaire, and more general tools like the Total Symptom Score can aid diagnosis, characterization, and monitoring of pain in patients with FD. These tools can be complemented by more objective and quantifiable sensory testing. In male and female patients of any age, pain related to FD can be an early indication to start disease?specific enzyme replacement therapy before potentially irreversible organ damage to the kidneys, heart, or brain occurs. Conclusion: To improve treatment outcomes, pain should be diagnosed early in unrecognized or newly identified FD patients. Treatment should include: (a) enzyme replacement therapy controlling the progression of underlying pathology; (b) adjunctive, symptomatic pain management with analgesics for chronic neuropathic and acute nociceptive, and inflammatory or mixed pain; and (c) lifestyle modifications. äPain in Fabry Disease: Practical Recommendations for Diagnosis and Tre(epmc).pdf DeepDyve Pubget Overpricing